Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis()()()

BACKGROUND: Mortality is high for severe alcohol-associated hepatitis (AH). Corticosteroids are the standard of care for patients without contraindications. Recent data showed that interleukin-1β receptor antagonist anakinra attenuated inflammation and liver damage. We designed a multicenter, double...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Wanzhu, Gawrieh, Samer, Dasarathy, Srinivasan, Mitchell, Mack C., Simonetto, Douglas A., Patidar, Kavish R., McClain, Craig J., Bataller, Ramon, Szabo, Gyongyi, Tang, Qing, Barton, Bruce A., Radaeva, Svetlana, Sanyal, Arun J., Shah, Vijay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869411/
https://www.ncbi.nlm.nih.gov/pubmed/36698742
http://dx.doi.org/10.1016/j.conctc.2023.101074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869411/
https://www.ncbi.nlm.nih.gov/pubmed/36698742
http://dx.doi.org/10.1016/j.conctc.2023.101074

Ejemplares similares